After MCAO, animals treated with IL-10 deficient B cells exhibited larger infarct volumes (Ortega et al., 2020), while the administration of enriched IL-10-positive B cells resulted in a reduction in ischemic infarct volume and stroke-induced splenic atrophy (Bodhankar et al., 2014). The gene discussed is IL10; the disease is stroke disorder.